Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Losartan Effects on Macrophage Differentiation in Diabetic Nephropathy
NCT02768948Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- May 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of telmisartan in diabetic nephropathy (DN) (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Number of differentiation marker at 6 months. Started May 2017; status: completed.
02
Drugs
telmisartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02768948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768948.